Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
In today's business landscape, continuous change is the new reality and navigating it effectively is essential to activating strategy and moving organisations forward. In this research, Criticaleye Partner, Accen...
Transitioning to a more sustainable economic system that balances economic development with maintaining healthy global ecosystems requires significant investment. In this fifth edition of their annual Green Economy R...
It's no secret that the role of the CFO is changing, with added onus on the finance exec taking an active role in shaping business strategy, as well as the impact of AI and machine learning on the traditional financ...
Displaying 1 to 3 of 1,697
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
